Literature DB >> 15209204

Screening for ovarian cancer: recommendation statement.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15209204      PMCID： PMC1466669          DOI： 10.1370/afm.200

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN： 1544-1709            Impact factor:   5.166


× No keyword cloud information.
  17 in total

1.  Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

Authors:  C Rodriguez; A V Patel; E E Calle; E J Jacob; M J Thun
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

2.  The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

Authors:  J R van Nagell; P D DePriest; M B Reedy; H H Gallion; F R Ueland; E J Pavlik; R J Kryscio
Journal:  Gynecol Oncol       Date:  2000-06       Impact factor: 5.482

3.  Multimodal approach to screening for ovarian cancer.

Authors:  I Jacobs; I Stabile; J Bridges; P Kemsley; C Reynolds; J Grudzinskas; D Oram
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

4.  Screening for ovarian cancer: a pilot randomised controlled trial.

Authors:  I J Jacobs; S J Skates; N MacDonald; U Menon; A N Rosenthal; A P Davies; R Woolas; A R Jeyarajah; K Sibley; D G Lowe; D H Oram
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

5.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Authors:  J K Gohagan; P C Prorok; R B Hayes; B S Kramer
Journal:  Control Clin Trials       Date:  2000-12

6.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

Review 7.  Should women with familial ovarian cancer undergo prophylactic oophorectomy?

Authors:  K Kerlikowske; J S Brown; D G Grady
Journal:  Obstet Gynecol       Date:  1992-10       Impact factor: 7.661

8.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

Authors:  A S Whittemore; R Harris; J Itnyre
Journal:  Am J Epidemiol       Date:  1992-11-15       Impact factor: 4.897

9.  The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.

Authors: 
Journal:  Gynecol Oncol       Date:  2002-12       Impact factor: 5.482

10.  Menopausal hormone replacement therapy and risk of ovarian cancer.

Authors:  James V Lacey; Pamela J Mink; Jay H Lubin; Mark E Sherman; Rebecca Troisi; Patricia Hartge; Arthur Schatzkin; Catherine Schairer
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
View more
  18 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

Review 2.  Ovarian cancer screening.

Authors:  Usha Menon
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262

3.  Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization.

Authors:  Andres Aguirre; Yasaman Ardeshirpour; Mary M Sanders; Molly Brewer; Quing Zhu
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

4.  Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.

Authors:  Seijeoung Kim; Therese A Dolecek; Faith G Davis
Journal:  Soc Sci Med       Date:  2010-04-22       Impact factor: 4.634

5.  Prophylactic bilateral oophorectomy at time of hysterectomy for women at low risk: acog revises practice guidelines for ovarian cancer screening in low-risk women.

Authors:  C A Larson
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

6.  Surgical menopause and nonvertebral fracture risk among older US women.

Authors:  Kimberly K Vesco; Lynn M Marshall; Heidi D Nelson; Linda Humphrey; Joanne Rizzo; Kathryn L Pedula; Jane A Cauley; Kristine E Ensrud; Marc C Hochberg; Diana Antoniucci; Teresa A Hillier
Journal:  Menopause       Date:  2012-05       Impact factor: 2.953

Review 7.  Update in women's health for the general internist.

Authors:  Eleanor Bimla Schwarz; Megan McNamara; Redonda G Miller; Judith M E Walsh
Journal:  J Gen Intern Med       Date:  2010-09-08       Impact factor: 5.128

8.  Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.

Authors:  Jillian T Henderson; Cynthia C Harper; Sarah Gutin; Mona Saraiya; Jocelyn Chapman; George F Sawaya
Journal:  Am J Obstet Gynecol       Date:  2012-11-22       Impact factor: 8.661

9.  Physicians' beliefs about effectiveness of cancer screening tests: a national survey of family physicians, general internists, and obstetrician-gynecologists.

Authors:  Jacqueline W Miller; Laura-Mae Baldwin; Barbara Matthews; Katrina F Trivers; C Holly Andrilla; Denise Lishner; Barbara A Goff
Journal:  Prev Med       Date:  2014-07-17       Impact factor: 4.018

Review 10.  Biomarker testing for ovarian cancer: clinical utility of multiplex assays.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.